Literature DB >> 10404516

Gene expression pattern in human monocytes as a surrogate marker for systemic inflammatory response syndrome (SIRS).

G Wiegand1, K Selleng, M Gründling, R S Jack.   

Abstract

BACKGROUND: Systemic inflammatory response syndrome (SIRS) is a mild inflammatory episode which, in a minority of patients, may deteriorate into septic shock. In the mouse, injection of bacteria or bacterial endotoxin induces systemic inflammation through the activation of blood monocytes, which leads to lethal shock. A number of intervention strategies have been shown to prevent progression to shock in mouse model systems. However, recent clinical trials of a number of these therapeutic strategies in patients have been uniformly disappointing. In contrast to the situation in the mouse models, there may be many different ways to initiate systemic inflammation in patients and not all of them need necessarily involve activation of blood monocytes. If there is no unifying mechanism behind the induction of systemic inflammation in patients and no common rules governing its development, then it is unlikely that generally applicable therapeutic strategies will be found that can prevent progression into shock.
MATERIALS AND METHODS: We used differential display to compare gene expression patterns in monocytes of recent-admission multi-trauma patients with clinically diagnosed SIRS to the patterns in monocytes of healthy controls.
RESULTS: Of seven differentially displayed bands that were recovered and sequenced, five were associated with SIRS and two were preferentially expressed in the monocytes of healthy controls.
CONCLUSION: The data show that monocytes of SIRS patients are in an activation state that is different from that of monocytes from the healthy controls, that monocytes from many individual patients share similar patterns of differentially expressed sequences, and that by this criterion, the multi-trauma SIRS patients are a remarkably coherent group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404516      PMCID: PMC2230296     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  13 in total

1.  Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction.

Authors:  P Liang; A B Pardee
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

2.  Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization.

Authors:  S M Welford; J Gregg; E Chen; D Garrison; P H Sorensen; C T Denny; S F Nelson
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

3.  Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR).

Authors:  D Bauer; H Müller; J Reich; H Riedel; V Ahrenkiel; P Warthoe; M Strauss
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

4.  Generation of competitor DNA fragments for quantitative PCR.

Authors:  K Uberla; C Platzer; T Diamantstein; T Blankenstein
Journal:  PCR Methods Appl       Date:  1991-11

5.  Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.

Authors:  M A Freudenberg; D Keppler; C Galanos
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

6.  Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock.

Authors:  P Li; H Allen; S Banerjee; S Franklin; L Herzog; C Johnston; J McDowell; M Paskind; L Rodman; J Salfeld
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

7.  Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients.

Authors:  D Pittet; S Rangel-Frausto; N Li; D Tarara; M Costigan; L Rempe; P Jebson; R P Wenzel
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

8.  Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz; R A Balk
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

9.  Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.

Authors:  M A Rogy; T Auffenberg; N J Espat; R Philip; D Remick; G K Wollenberg; E M Copeland; L L Moldawer
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

Authors:  K W McIntyre; G J Stepan; K D Kolinsky; W R Benjamin; J M Plocinski; K L Kaffka; C A Campen; R A Chizzonite; P L Kilian
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.